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Abstract
Background: Process evaluations are an important component in the interpretation and understanding of
outcomes in trials. The Online Remote Behavioural Intervention for Tics (ORBIT) study is a randomized controlled
trial evaluating the effectiveness of an Internet-delivered behavioural intervention (called BIP TIC) compared to an
Internet-delivered education programme aimed at children and young people with tics. A process evaluation will
be undertaken alongside the main trial to determine precisely how the behavioural intervention works and
ascertain whether, and if so, how, the intervention could be successfully implemented in standard clinical practice.
This protocol paper describes the rationale, aims, and methodology of the ORBIT trial process evaluation.
Methods: The process evaluation will have a mixed-methods design following the UK Medical Research Council
2015 guidelines, comprising both quantitative and qualitative data collection. This will include analysing data usage
of participants in the intervention arm; purposively sampled, semi-structured interviews of parents and children,
therapists and supervisors, and referring clinicians of the ORBIT trial, as well as analysis of qualitative comments put into
the online therapy platform by participants at the end of treatment. Qualitative data will be analysed thematically.
Quantitative and qualitative data will be integrated in a triangulation approach, to provide an understanding of how
the intervention works, and what resources are needed for effective implementation, uptake and use in routine clinical
care.
Discussion: This process evaluation will explore the experiences of participants, therapists and supervisors and
referring clinicians of a complex online intervention. By contextualising trial efficacy results, this will help understand
how and if the intervention worked and what may be required to sustain the implementation of the treatment long
term. The findings will also aid in our understanding of factors that can affect the success of complex interventions.
This will enable future researchers developing online behavioural interventions for children and young people with
mental health and neurological disorders to gain invaluable information from this process evaluation.
Trial registration: International Standard Randomised Controlled Trials Number, ISRCTN70758207. Registered on
20 March 2018.
ClinicalTrials.gov, NCT03483493. Registered on 30 March 2018.
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Background
There is growing interest within health care as to how
advances in technology can be used in developing effect-
ive treatments for people with psychological and neuro-
logical disorders [1]. Although children and young
people (CYP) (i.e. individuals up to the age of 18 years)
make up a large proportion of the population with psy-
chiatric and neurological conditions [2, 3], there is
limited access to evidence-based treatments aimed at re-
ducing symptoms in this population. Access to services
for CYP is the lowest amongst all demographics [4] with
only 25% of CYP receiving appropriate treatments [5].
Behavioural treatments in particular are desirable and
highly recommended by healthcare professionals as a
first-line treatment in reducing symptoms in CYP due to
the limited side effects relative to pharmacotherapy [6,
7]. However, these treatments are often difficult to
access and CYP may avoid face-to-face therapy due to
stigmatization [8]. Due to their affinity to technology, a
promising development that may benefit CYP are online
or digital health interventions (DHI). Randomized con-
trolled trials (RCTs) have shown that DHIs can be
effective in treating psychological and neurological
symptoms for CYP [9–12] but they can also be ineffect-
ive [13, 14]. Hence, before any new DHI is introduced,
clinicians, patients and commissioners need robust re-
search to determine efficacy. However, data on efficacy
alone is insufficient to inform effective implementation
and uptake in routine health care. Data are also required
on acceptability, uptake and use of the intervention,
including any apparent impact of the digital divide on
health inequalities and on the resources and activities
required to achieve effective implementation.
Little is known about how, and for whom in particular,
DHIs work and what makes them effective in one con-
text and not another and the barriers to effective imple-
mentation [15, 16]. The UK Medical Research Council
(MRC) has developed specific guidelines for conducting
a process evaluation of complex interventions to assess
quality of implementation (fidelity), dose, reach and
adaptations and to analyse causal mechanisms and iden-
tify any contextual factors [17]. Process evaluations can
therefore aid interpretation and understanding of trial
outcomes and inform future refinements of the interven-
tion under study.
Grant et al. [18] have identified the importance of out-
lining process evaluation methodology a priori and
consider the publication of process evaluation protocols
as “best practice” in order to improve trial quality.
Despite the increasing popularity in conducting process
evaluations of complex interventions [16, 19] and the
aforementioned importance of publishing protocols, ex-
plicit guidelines for publishing process evaluation proto-
cols are limited [20].
Using previously published process evaluations of
complex interventions protocols as a guide [21, 22], here
we outline the methodology and describe the planned
process evaluation of the Online Remote Behavioural
Intervention for Tics (ORBIT) trial.
The ORBIT intervention
The ORBIT trial and its BIP TIC intervention have been
described in detail previously as part of the main trial
protocol [23] (03/01/2019; version 3.0), a brief summary
is given to provide context to the process evaluation
design. The ORBIT trial is a 10-week, parallel group,
single-blind RCT with an internal pilot. ORBIT aims to
evaluate the efficacy of an online, remote, therapist-
supported and parent-guided behavioural intervention
for tics, which was initially developed and piloted in
Sweden and called BIP TIC [24]. The comparator is an
online, remote, therapist-supported and parent-guided
psychoeducation programme for tics. Participants will be
recruited from clinics, Patient Identification Centres
(PICs) across National Health Service (NHS) Trusts, or
from the two study sites involved in the trial (Queen’s
Medical Centre (QMC), Nottingham and Great Ormond
Street Hospital (GOSH), London), or via a tic disorder
charity (Tourettes Action), the ORBIT study website or
social media. Participants need to be 9–17 years old and
be suspected or confirmed as having Tourette syndrome
(TS) or chronic tic disorder (CTD) and must not have
had any form of behavioural treatment for tics in the last
12 months or a change in medication for tics in the
previous 2 months. Participants will be followed up mid
treatment and at 3, 6, 12 and 18 months post-
randomization.
Participants will be randomized to one of two groups.
The intervention group will receive 10 self-help modules
of behavioural therapy delivered over a period of 10–12
weeks, which will be accessed via a secure online
platform [24]. The behavioural therapy will follow
evidence-based exposure and response prevention (ERP)
therapeutic principles, whereby patients learn strategies
for managing their tics through allowing premonitory
urge sensations to come to the fore and actively tolerate
the premonitory urges and suppress their tics. In doing
so, the child masters their ability to tolerate the urge,
control their tics, and is able to do so for an increasing
amount of time in a hierarchical manner. The child also
receives education about tics for the family and others,
such as teachers, friends and family. Throughout the
10–12 weeks, participants will have access to a therapist
and their role is to encourage participants to engage
with the treatment content and its homework assign-
ments, and answer any queries that participants may
have. The parent components contain information about
how to support their child and various coping strategies
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for themselves. Previous studies have shown that ERP is
effective in reducing tics [25, 26], with European clinical
guidelines [25] and a National Institute of Health
Research Health Technology Assessment Evidence
Synthesis [27] recommending that behavioural therapy
should be offered as a first-line intervention for tics in
CYP. The primary outcome measure is the severity of tics
as measured on the Total Tic Severity Score (TTSS) sub-
scale of the Yale Global Tic Severity Scale (YGTSS) [28].
The target sample size for the ORBIT trial is 220 (110 in
the intervention arm and 110 in the control arm).
Overall, the ORBIT trial aims to evaluate the clinical
effectiveness of an online behavioural treatment for CYP
with tics compared to online tic-related education in re-
ducing tics, as measured by the YGTSS TTSS. Further-
more, the trial aims to evaluate the cost effectiveness of
the online treatment and to estimate the longer-term
impact on patient outcomes and health service costs.
The ORBIT process evaluation aims and objectives
The aim of the ORBIT process evaluation is to under-
stand the causes of the observed behaviour change using
data obtained from the RCT, and in particular, to ex-
plore the fidelity of intervention delivery, acceptability of
the intervention and reasons for observed variation in
uptake and use, and to consider the resources and im-
plementation processes required.
Specific objectives are:
1. To assess the fidelity, reach and dose of
intervention delivery.
2. To explore whether any of the intervention features
were adapted for individual needs enabling potential
recommendations for adaptations.
3. To explore BIP TIC from the perspective of
children, parents, therapists and clinicians in order
to gain a deeper understanding of potential
mechanisms underlying participant’s behaviour
change whilst probing for any unexpected
consequences.
4. To evaluate any factors external to BIP TIC that
may have affected delivery (i.e. the environment and
its characteristics) or whether its mechanisms of
impact worked as intended.
5. To consider the resources and implementation
processes required for effective implementation,
uptake and use of the intervention.
The design of this process evaluation is guided by
MRC directives on the process evaluation of complex in-
terventions [17]. The MRC outlines three essential com-
ponents in understanding how outcomes are achieved:
implementation, mechanisms of impact and context.
The application of these guidelines in the context of the
ORBIT trial will be as follows:
1. Implementation: an exploration as to how delivery
of BIP TIC was achieved by examining quality
(fidelity) and quantity (dose) of what was
implemented. The structures and processes through
which BIP TIC was delivered as intended, any
adaptations made, and establishing the extent to
which BIP TIC reached its intended audience
(reach).
2. Mechanisms of impact: an examination of the
causal mechanisms through which BIP TIC
produces change by understanding how participants
interact with the intervention. This also allows for
an identification of any unexpected pathways and
consequences.
3. Context: an exploration of any factors external to
BIP TIC, which may have influenced its
implementation (e.g. comorbidities, home life for
the family, school life for the child, system factors
in health services). MRC guidelines outline that a
process evaluation should address how context
affects implementation and outcomes (i.e. change).
They further suggest that when investigating
impacts of context on outcomes, it is helpful to
relate contextual variations to a priori hypothesised
causal mechanisms, or those emerging from
qualitative analysis, in order to generate insights
into context-mechanism-outcome patterns. Thus,
in order to explore context, we will be as flexible as
possible in data analysis.
MRC guidance on the development and evaluation of
complex interventions notes that identifying and devel-
oping a theoretical understanding of the likely process of
change is a key early task for developing a complex
intervention or evaluating one that has already been de-
veloped. MRC guidelines stipulate an important compo-
nent of a process evaluation is to outline the processes
of the intervention and the outcomes it aims to achieve
by means of a logic model. The logic model for the study
is shown in Table 1.
Overall design
The overall design of the ORBIT process evaluation is a
mixed-methods study using purposively sampled qualita-
tive data together with quantitative data from the trial.
This will involve semi-structured interviews with chil-
dren, parents, therapists and supervisors and clinicians,
and analysis of online feedback from participants to-
gether with data from the online platform, such as total
therapist time, number of chapters viewed and number
of log-ins.
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The schedule of the ORBIT process evaluation proce-
dures is displayed in Fig. 1. In Additional file 1 a popu-
lated Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) checklist is provided [29]
and in Additional file 2 a CONSORT-EHEALTH: Im-
proving and Standardizing Evaluation Reports of Web-
based and Mobile Health Interventions is provided [30].
Ethical approval for the process evaluation was ob-
tained from North West - Greater Manchester Central
Research Ethics Committee as part of the ORBIT trial
(REC: 18/NW/0079).
Qualitative data collection
Qualitative data will be collected by interviewing participants
in the BIP TIC intervention (both CYP and parents, either
separately or as a dyad), therapists and supervisors and refer-
ring clinicians. Interviews with therapists and supervisors in-
volved in the ORBIT trial will be conducted early in the trial
and near the end of recruitment in order to gain an under-
standing of their experience at different time points. All in-
terviews will be conducted either by telephone or by the
WebEx videoconferencing application. In addition, at the
end of treatment participants are asked within the BIP TIC
platform questions including what the most important thing
they have learnt from treatment, how the treatment has
helped, if the treatment caused any difficulties to participants,
and any other comments they may wish to add. These data
will be put into BIP TIC and then will be exported to an
excel spreadsheet and content analysis will be performed.
Sampling and recruitment for interviews
Children and parents
In line with previous literature [31, 32], four semi-
structured interview schedules were developed (see Add-
itional file 3). The child and parent interview schedules
were drafted and underwent revision from the main re-
searcher and three academics. Questions include (1) how
they found out about the ORBIT trial; (2) why they took
part; (3) their initial expectations; (4) their views of the
content, structure, and the different chapters of the online
programme; (5) what impact the therapy had, if any, on
their tics; (6) what they found most and least helpful; (7)
barriers to participation; (8) how they felt about commu-
nicating with their therapist; (9) if they would alter any-
thing about the programme and (10) their
recommendations for improvement of the interventions
and their overall experience of participating in the trial.
The revised drafts were sent to two dyads of the Patient
and Public Involvement (PPI) group - including two chil-
dren with tics - for feedback and were revised accordingly.
All interviews will be carried out with CYP and par-
ents of CYP following completion of the intervention at
the 3-month (primary end-point) follow-up assessment
in the main trial. Recruitment for the interviews began
in August 2018 through the following methods:
 Following completion of the primary end-point, the
researcher conducting the follow-up assessment asks
participants if they are willing to be contacted about
taking part in an interview. If the participant agrees,
the researcher informs the process evaluation
researcher who makes contact with the family.
 Researchers at both QMC and GOSH arrange a
convenient date, time and method for interviewing
the participants who agree to this following their
primary end-point follow-up assessment.
 A proportion of the participants are to be contacted
by telephone following their primary end-point
assessment by the main researcher of the process
evaluation.
Table 1 Logic model for the BIP TIC intervention
Problem Delivery
mechanisms
Intervention (What is to be
implemented)
How delivery achieved
Mechanisms
of impact
Intended outcomes Impact
Growing demand for
behavioural therapy as a
first line treatment
Lack of specialised care
for CYP with tics
ERP
Education on tics
and
comorbidities
Therapist reinforcement
Follow-up sessions
Therapist support
Knowledge about tics
and management
How people
feel about BIP
TIC
Motivation
levels
Treatment
credibility
Reduced tics
Reduced co-morbid
psychological
symptomology of
psychiatric condition
Increased parental and
CYP awareness and
knowledge
Improved function
(e.g. school, social
relations, leisure activities)
Improved provision of care for
CYP with tics
Increase in behavioural
therapy as a first line treatment
Health economic aspects
Parent resources 10 modules at weekly
intervals
Unanticipated
consequences
Therapist contact Rewards
Regular practice
Mediators
Parental support
*CYP children and young people, ERP exposure and response prevention
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Participants will only be contacted if they gave explicit
written consent to participate in an interview for the
ORBIT trial and, for a child under 16 years old, assent was
obtained with parental consent (see Additional file 4). Par-
ticipants will be purposively sampled with the intention of
collecting data from a diverse cohort to obtain varying
views on the intervention. This will include ensuring per-
spectives from a range of ages, gender and ethnicity, and
levels of interaction with the intervention are voiced. We
anticipate that this sampling strategy will result in suffi-
cient heterogeneity to provide examples of both relatively
poor and relatively good adoption, delivery and
maintenance, and will allow us to identify barriers and fa-
cilitators to implementation and to generate hypotheses
about factors that may be associated with differing out-
comes for CYP in the intervention arm.
The target sample size for participant interviews is >
20 CYP and > 20 parents of CYP. This will ensure that
data reach a level of saturation [33] and enable diversity
of views.
Therapists
The therapist interview schedules were drafted and were
revised by the main researcher and three academics,
Fig. 1 Schedule of ORBIT and process evaluation procedures. *t1, mid-treatment (3 weeks); t2, mid-treatment (5 weeks); t3, primary end point (3
months); t4, 6 months; t5, 12 months; t6, 18 months; YGTSS, Yale Global Tic Severity Scale; TTSS, Total Tic Severity Score; ERP, exposure and
response prevention
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with input from a therapist and clinical researcher with
specific expertise in the field. Therapist questions in-
clude (1) their role on the ORBIT trial; (2) how they
found out about ORBIT and why they became involved;
(3) what specific skills they felt a therapist needed for
the programme; (4) any training needs identified; (5)
how they managed ORBIT around other commitments;
(6) their experiences of receiving/giving supervision
sessions; (7) if the therapy is being delivered as planned;
(8) their experiences of interacting with participants; (9)
their views on the two trial arms and (10) and their
recommendations for future use.
Therapists will initially be interviewed individually early
in the trial (halfway through the study) and then inter-
viewed again near the end of the trial. This will allow for a
range of experiences at different time points to investigate
trial progression. The target number of therapist inter-
views is > 5, of which 2 will be interviews with supervisors.
Clinicians
Clinicians refer to any healthcare professional (usually a
physician) who were responsible for referring participants
to the ORBIT trial. Whilst they were not explicitly in-
volved in the ORBIT trial, the main purpose of interview-
ing them was to gain their views on potential
implementation in routine care. The clinician interview
schedules were drafted and underwent revision from the
same team and were guided by normalization process the-
ory (NPT) [34, 35]. As the purpose of the clinician
interviews is to explore their views about the feasibility of
integrating the intervention into everyday practice,
including any potential barriers to or facilitators of this,
the NPT framework approach seemed the most appropri-
ate. The clinician interview schedule questions aim at eli-
citing information on how they became involved in the
ORBIT trial and why, their experience of recruiting for
the trial including factors that affected recruitment, and
how the NHS could incorporate the intervention into
everyday practice. Clinicians will be purposively selected
from the PIC sites involved in recruiting for ORBIT and
the target number of clinician interviews is > 5.
Quantitative data collection
Online data will be collected and recorded from partici-
pants throughout the trial. These include the following
measures: total therapist time; therapist time specific to
each therapist; therapist time specific to each child and
parent; total number of characters submitted by child
and parent (as part of communication messages via the
online system); total number of logins for child and par-
ent; average time between each login (in days) for child
and parent; average pages visited per login for child and
parent and the five most frequently visited pages per
child and parent. These data will be amalgamated and
entered into a centralised online database whereby the
main researcher will then extract this data for analysis as
part of the process evaluation.
Trial data
As part of the quantitative measures for the process evalu-
ation, we will also extract and analyse change in YGTSS
TTSS from baseline to the primary end-point, which will
be used to inform behaviour change. As mentioned, this is
a key component of the MRC guidance on process evalua-
tions. Demographic data, overall symptom improvement as
measured on the Clinical Global Impressions Scale (CGI)
for improvement [36], depressive symptoms at baseline as
measured on the Mood and Feelings Questionnaire (MFQ;
child-completed version) [37] and service-use data as mea-
sured by the modified Child and Adolescent Service Use
Schedule (CA-SUS) [38] will also be analysed. These data
will be used to measure context and the mechanisms of
change. The target sample size for all quantitative data
is 110 participants. Table 2 presents a summary of the
Table 2 Process evaluation components, areas of research, explanatory data and outcomes
Process evaluation components Research questions Explanatory data Outcomes
Implementation (what is implemented
and how?)
➢ Fidelity of implementation
➢ Dose of intervention delivered
➢ Adaptations
➢ Reach
➢ Therapist contact/time (n = 110)
➢ BIP TIC adherence (n = 110)
➢ Usage metrics (n = 110)
➢ Clinician (n > 5), children and
parent (n= > 20), therapist (n= > 5)
interviews
➢ Engagement and satisfaction
with intervention
Mechanisms of impact (how does it
produce change?)
➢ Mediators and moderators
➢ Unexpected pathways and
consequences
➢ Usage metrics
➢ Therapist contacts
➢ Clinician, children and parent,
therapist interviews
➢ YGTSS TTTS change
Context (how do factors external to the
intervention affect implementation and
change?)
➢ Factors related to
improvement in YGTSS TTSS,
fidelity of delivery
➢ Demographic data
➢ Clinician, children and parent,
therapist interviews
➢ Service use
➢ Comorbidities
➢ Baseline severity of tics
➢ YGTSS TTTS change
➢ Engagement with intervention
aYGTSS Yale Global Tic Severity Scale, TTSS Total Tic Severity Score, BIP TIC Internet-delivered behavioural intervention
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explanatory data sources that will be used to inform each
component of the process evaluation.
Data analysis
Qualitative data will be exported and analysed in QSR
International’s NVivo 12 Software [39] and quantita-
tive data will be exported and analysed in SPSS (ver-
sion 25.0) [40]. Process evaluation data will be
analysed autonomously of the main outcome data of
the ORBIT trial.
Qualitative data analysis
All interviews will be recorded either by the WebEx vid-
eoconferencing application or by Dictaphone and then
transcribed verbatim. Transcripts will be checked for ac-
curacy against the recordings, with any corrections made
as appropriate. Prior to importing transcripts into QSR
NVivo 12, any reference to places, clinicians, therapists,
and/or family members that may reveal participants’
identity will be redacted, and all participants’ names will
be anonymised. The interviewer will take notes during
all interviews.
As the process evaluation is a combination of explor-
ation and description, thematic analysis will be used to
identify, analyse and report patterns within the tran-
scribed interviews. Thematic analysis is widely used
within the field of psychology and is considered the most
flexible qualitative analytical process [41]. More broadly,
the framework method [42] of analysis will be employed,
as it is most commonly used for the thematic analysis of
semi-structured interviews [43]. Moreover, Ritchie and
Spencer [42] outline four types of research questions
that they believe framework analysis can helpfully ad-
dress: (1) contextual - identifying the form and nature of
what exists (e.g. what is the nature of people’s expe-
rience?); (2) diagnostic - examining the reasons for, or
causes of, what exists (e.g. why are services or pro-
grammes not being used?); (3) evaluative - appraising
the effectiveness of what exists (e.g. what affects the suc-
cessful delivery of programmes or services?) and (4) stra-
tegic - identifying new theories, policies, plans or actions
(e.g. how can systems be improved?). As the process
evaluation covers all of these questions, we feel this is
the appropriate methodology to use.
Ritchie and Spencer [42] suggest five key stages of
framework analysis: familiarisation, identifying a the-
matic framework, indexing, charting and mapping and
interpretation. During the familiarisation stage, the main
researcher will immerse himself in the data by listening
and/or watching back the interviews, reading transcrip-
tions and studying observational notes whilst listing key
ideas and recurring themes. The data will then be ana-
lysed to identify key issues, concepts, themes, and sub-
themes drawing on both a priori and emergent issues.
Next, the transcripts will be coded and indexed into
framework categories by systematically applying the the-
matic framework to each interview. The indexed data
will be summarized for each category and organised in
chart form. This process will involve working through
each framework category, summarizing all data that have
been indexed to that category, and then providing a
summary for each category for each participant, using
headings and subheadings. Consequently, key character-
istics of the holistic dataset will be mapped and inter-
preted. An independent coder will double-code a subset
of transcripts to identify emergent patterns and themes
relating to participants’, therapists’ and clinicians’ experi-
ences of the ORBIT trial. Charted data will be annotated
independently and the findings discussed, which will
allow for refinement and amendment of data in an itera-
tive process. Once confidence in the congruity and
meaningfulness of interpretation is established between
researchers, we will review the remaining interviews to
establish whether our understanding has reached
acceptability.
The large amount of data collected for the process
evaluation encouraged us to use computer-assisted
qualitative data analysis software (CAQDAS). The CAQ-
DAS package, QSR NVivo 12, is fully integrated with
framework analysis and this will be used to categorise
data and document any themes and sub-themes. Online
feedback given by participants at the end of therapy will
be analysed using content analysis and integrated into
the aforementioned framework.
Quantitative data analysis
Quantitative data from the online platform will be ana-
lysed descriptively by calculating total numbers and per-
centages and mean and standard deviation or if the data
are not normally distributed, the median and range. This
will provide information on intervention delivery, in-
cluding the implementation of different components and
fidelity. The independent samples t-test and the chi-
squared test will be used to explore any significant dif-
ferences within the intervention group. Data that are not
normally distributed, will be analysed using non-
parametric alternatives (i.e. Kruskal–Wallis H and
Mann–Whitney U tests), using a significance level of
P < 0.05.
Mixed methods analysis
Qualitative and quantitative data will be analysed separ-
ately and then mixed during analysis in a methodological
approach known as triangulation [44]. Both qualitative
and quantitative data will be given equal importance, as
both sets of data are central to addressing the research
questions posited by the process evaluation. A Good
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Reporting of a Mixed Methods Study (GRAMMS) [45]
checklist is provided in Additional file 5.
Qualitative data and preliminary qualitative analysis
will be coded synchronously with the analysis of descrip-
tive statistics of participants’ online data. Thus, the de-
scriptive data will aid in the refinement and amendment
of questions central to qualitative data collection. In
other words, key themes may emerge from the quantita-
tive data, which could then be further explored or
clarified from qualitative data, and vice versa. The main
researcher will integrate and compare outcomes from
the various datasets guided by the triangulation protocol.
The aim of this is to create a matrix of converging data-
sets to assess outcomes where there is agreement or dis-
sonance, and where themes or outcomes emerge in one
dataset but not another. Once the matrix of outcome
synthesis from the various datasets is finalised, it will be
used to emphasise the mechanisms of impact, imple-
mentation fidelity and, more broadly, explain the
outcomes of the trial.
Integration of findings
The process evaluation data will be analysed prior to
knowing the main ORBIT trial results, with the two ana-
lyses being independent of each other. The ORBIT trial
team will be unaware of the findings of the process
evaluation until the primary outcomes from the main
trial have been analysed. Once both trial and process
evaluation analyses are complete, combined qualitative
and quantitative data may aid in the development of hy-
potheses about the potential successful implementation
in one context over another and how and why some
components were delivered successfully and others were
not. Furthermore, the analysis of different components
may aid in the identification of causal mechanisms and
how and why individual intervention components were
more effective than others. Following quantitative ana-
lysis of ORBIT trial data, qualitative data from the
process evaluation can potentially be used to help ex-
plain the outcomes of the trial. Additional analyses can
then be conducted to test hypotheses emanating from
integration of process evaluation data with trial out-
comes, drawing together the findings to understand why
the intervention worked (or not), context and implica-
tions for further dissemination to improve provision of
care for CYP with tics.
Discussion
This protocol outlines the rationale, design and method-
ology for the planned mixed methods process evaluation
of BIP TIC, a complex online intervention for CYP with
tics. The process evaluation is designed to explore the
implementation of the online intervention and provide a
holistic view of trial outcomes. By explicitly outlining
our process evaluation methodology, guided by MRC
framework of complex intervention trials [17], this paper
adds to the literature on process evaluation protocols
using a mixed methods design. In doing so, this will im-
prove the integrity of this process evaluation and, as
mentioned, there is growing emphasis on the importance
of publishing process evaluation protocols in advance to
improve overall trial quality and reporting [18].
The combined qualitative and quantitative process
evaluation data will support the homogenous interpret-
ation of the main outcome data from the ORBIT trial.
By illuminating how and why BIP TIC was effective or
not, the process evaluation will help elucidate a holistic
view of the intervention. Moreover, understanding the
mechanisms of impact and any contextual factors, these
data will augment the dissemination plan and may sup-
port the long-term implementation of the intervention.
The process evaluation will also offer insight into digital
interventions and may inform future development of
such health technologies.
Strengths and limitations
Conducting the process evaluation will contribute to
explaining the overall findings of the main RCT: the fac-
tors underlying positive and negative effects of different
aspects of BIP TIC. For example, if there were certain
negative outcomes from using BIP TIC, the process
evaluation will be an invaluable resource in elucidating
whether the intervention was inherently inadequate, if
there was a failure of implementation and if this was re-
lated to participants (e.g. lack of motivation) or context-
ual factors (e.g. pre-existing beliefs about online
therapy). This would help to improve the intervention
progressively.
In contrast, if there were positive outcomes from using
BIP TIC, the process evaluation will identify the core
components that made the intervention a success. For
example, if it was determined that an essential compo-
nent for promoting participants’ adherence to the inter-
vention was the use of parental support and therapist
encouragement, these findings will be crucial to the de-
velopment and implementation of future digital pro-
grammes aimed at CYP with tics.
By collecting data from a range of relevant stake-
holders (e.g. parents, children, therapists and supervisors
and clinicians) and combining quantitative and qualita-
tive data, we will gain a holistic understanding of the
mechanisms underlying the impact of the intervention.
Furthermore, the proposed sample size is adequate to
capture a comprehensive overview of perspectives,
generating rich data and analytical depth.
One potential limitation arising from this is that the
majority of participants who drop out of treatment are
more likely to refuse to be interviewed, which could lead
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to a more positive overall evaluation of the intervention.
We will attempt to overcome this by making a more
concerted effort to recruit participants who drop out of
treatment or, if this is not possible, those who complete
fewer modules. The main limitation in terms of future
implementation is that the environment/context will
be heavily influenced by this study being an RCT. It
would arguably be more appropriate to conduct a par-
allel implementation study; however, lack of resources
prohibit this.
Trial status
The trial and recruitment of participants for the process
evaluation is ongoing.
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